elderin 600 mg tablete s podaljšanim sproščanjem
lek d.d. - etodolak - tableta s podaljšanim sproščanjem - etodolak 600 mg / 1 tableta - etodolak
elderin 300 mg filmsko obložene tablete
lek d.d. - etodolak - filmsko obložena tableta - etodolak 300 mg / 1 tableta - etodolak
elderin tablete200 mg
tableta - etodolak
heplisav b
dynavax gmbh - površinski antigen hepatitisa b - hepatitis b - cepiva - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.
atacand 16 mg tablete
astrazeneca ab - cileksetilkandesartanat - tableta - cileksetilkandesartanat 16 mg / 1 tableta - kandesartan
atacand 8 mg tablete
astrazeneca ab - cileksetilkandesartanat - tableta - cileksetilkandesartanat 8 mg / 1 tableta - kandesartan
atacand 4 mg tablete
astrazeneca ab - cileksetilkandesartanat - tableta - cileksetilkandesartanat 4 mg / 1 tableta - kandesartan
candea hct 32 mg/25 mg tablete
lek d.d. - hidroklorotiazid; cileksetilkandesartanat - tableta - hidroklorotiazid 25 mg / 1 tableta cileksetilkandesartanat32 mg / 1 tableta; cileksetilkandesartanat 32 mg / 1 tableta - kandesartan in diuretiki
candea 4 mg tablete
lek d.d. - cileksetilkandesartanat - tableta - cileksetilkandesartanat 4 mg / 1 tableta - kandesartan
candea 32 mg tablete
lek d.d. - cileksetilkandesartanat - tableta - cileksetilkandesartanat 32 mg / 1 tableta - kandesartan